A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...
Home > Pressemitteilung: Precision diagnostics using peptides: ...
The gut microbiome has been shown to influence tumor growth and contribute to therapeutic resistance. Scientists have ...
Study Finds on MSN
Injectable filler made from donated skin shows promise for breast reconstruction in cancer patients
In A Nutshell Korean researchers developed SC Fill paste, an injectable tissue filler made from processed human skin that ...
Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first ...
Liv Hospital, the pioneer provider of personalized care, relies on the principle that each patient's cancer is different. The team undertakes to target the specific causes of a person's cancer rather ...
Marker Therapeutics (MRKR) is a clinical-stage immuno-oncology Company with the worldwide exclusive license of Multi-Antigen Targeted T cells, a ...
Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with ...
Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...
Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback